Complications of Celiac Disease by Jabeen, Rakhshinda
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Complications of Celiac Disease
Rakhshinda Jabeen
Abstract
Celiac disease is a small bowel disorder, due to defect in gluten diet, leading to 
mucosal inflammation, villous atrophy and crypt hyperplasia. For the diagnosis 
of celiac disease, one has to be on gluten free diet. Due to commonly available 
various serologic tests and histopathology, celiac disease, can be categorized as 
asymptomatic, silent or potential. Between 80 and 90% of all patients with celiac 
disease remained undiagnosed. Because of this late diagnosis, patients may develop 
various complications including anemia, bone loss, depression and cancers. Patients 
may have different types of anemia including iron deficiency, folic acid or B12 
deficiency. Any of these may occurred separately or may be manifested together. 
The same variation is seen in bone loss, starting from osteopenia, osteomalacia 
to osteoporosis and even dysplasias. Patient may develop lymphoma, gastric or 
oesophageal carcinomas as well. Celiac disease is also associated with other autoim-
mune illnesses as it is an autoimmune process by itself. The complications of celiac 
disease, is either due to direct consequence of celiac, or due to significant damage 
to the small intestine. With the early detection and diagnosis, the symptomatology 
and complications of celiac disease can be spared.
Keywords: complications, anemia, bone loss, cancers
1. Introduction
Celiac disease (CD) is one of the commonest malabsorptive syndromes, of 
either one or more nutrients. It was historically known as a disease of whites, but in 
recent era, it is as commonly seen in other parts of the world, including Asian and 
African countries [1, 2]. Because of its various categories starting from full blown 
CD, to completely asymptomatic variety, the clinical presentation dispersed among 
individuals. Although the commonest presentation is the gastrointestinal manifes-
tation but many individuals may present with malignancies associated with CD. The 
logical answer for this diverse and late manifestation may be due to prolonged 
breast feeding and late commencement of gluten diet among infants, which was the 
usual presenting age among infants [3]. The usual age of presentation of CD now is 
10–40 years [4].
In recent days, young patients still presenting with classical symptoms of CD, i.e. 
gastrointestinal, although may have complications at the time of initial presenta-
tion. The older individuals usually present with complications of different varieties, 
which make CD to diagnose late [5] (Table 1).
Among different categories of CD, including classical CD, atypical CD, asymp-
tomatic and latent CD the presentation are different and thus complications.
Classical celiac disease: The classical one, including three features: villous atro-
phy, symptoms of malabsorption and resolution of symptoms with gluten free diet. 
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This variant presents with malabsorption with vitamin and nutrient deficiencies. 
The malabsorptive symptoms include steatorrhea, weight loss, abdominal pain and 
diarrhea [6]. These patients also developed muscle weakness, muscle and bone pain, 
tooth enamel defect and lactase malabsorption [7]. These patients have various kind 
of nutrient and mineral deficiency including iron, folic acid, vitamin B12, vitamin 
D and zinc mostly, although they may have deficiency of other minerals as well.
Non-classical and atypical CD: The non-classical CD patients may have both 
gastrointestinal symptoms as in classical one, or they present with other associated 
manifestations of CD, including dermatitis herpetiformis, IgA deficiency, type 
1 diabetes mellitus, autoimmune thyroid illness, enamel defects and infertility. 
These patients also have severe mucosal damage and having specific celiac antibody 
pattern.
The asymptomatic or silent CD: This variant remained undiagnosed, or inci-
dentally diagnosed upon screening. They usually do not have any symptomatology 
except a little fatigue, which occurs after introduction of gluten free diet. Although 
these patients have classical architectural remodeling of intestinal mucosa as in 
classical CD, i.e. crypt hyperplasia and villous atrophy, but do not developed gastric 
symptoms; neither had they developed complications related to CD.
Latent CD: There are some patients among CD who have minor or no symptoms 
with normal jejunal mucosa, and remained asymptomatic if on gluten free diet. In 
this variant only 20% remained asymptomatic till adulthood and do not develop 
any complication of CD and having normal architecture throughout. The rest of the 
patients developed various degree of villous atrophy [8] and thus may develop com-
plications related to CD. These patients may develop malabsorption with multiple 
nutrient deficiencies and lymphoma.
Refractory CD: It is defined as persistent or recurrent symptoms typically diar-
rhea and weight loss with signs of malabsorption .despite on strict gluten free diet. 
It is accompanied by villous atrophy. Both the variants of refractory CD is associ-
ated with increased risk of lymphoma [9].
2. Gastrointestinal complications of CD
The classical CD may present with complications related to gastrointestinal 
symptomatology including recurrent foul smelling, bulky loose stools, and due to 
steatorrhea and flatulence. The mechanism of developing steatorrhea is primarily 
due to changes in jejunal mucosal function. Due to changes in jejunal brush border 
enzymatic function; these patients may develop secondary lactase deficiency, 
leading to diarrhea even after ingestion of milk and milk products, which further 
Gastrointestinal complications Non-gastrointestinal complications
Malabsorption Nutrient and mineral deficiencies
Intestinal lymphomas Osteoporosis/osteomalacia
Collagenous sprue Dental defects
Other GI malignancies Idiopathic pulmonary hemosiderosis
Glomerular IgA nephropathy
Infertility
Cardiomyopathy/myocarditis
Table 1. 
Complications of celiac disease.
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increases the development of complications [10]. In cases of extensive involvement 
of ileum, patients with CD may complicate with bile acid malabsorption result-
ing in bile acid induced fluid secretin in the colon. Crypt hyperplasia may lead to 
endogenous fluid secretion (Figures 1 and 2).
CD presenting in early age may complicate with short stature or stunted growth 
due to deficiency of multiple nutrients and minerals. These patients may also have 
severe weight loss, anemia of different types, and osteopenia. Due to shifting of 
classical symptoms to asymptomatic variety, patients with CD, may presents with 
irritable bowel syndrome type symptoms.
An association of CD is seen with gastroesophageal reflux disease, and it is much 
higher in CD than controls. These patients usually responded on gluten free diet 
within 3 months’ time [11]. Eosinophilic esophagitis is another common complica-
tion among patients with CD. Patients with persistent reflux or dysphagia should be 
evaluated for CD [12].
Because same pro-inflammatory polymorphism of the IL-23, receptor in both 
ulcerative colitis and CD, they may co-exist. The incidence of ulcerative colitis is 
Figure 1. 
Comparison of blunting and flattening of villi with normal mucosa (left) in CD.
Figure 2. 
Villous atrophy in CD.
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much higher than Crohn’s disease in patients with CD [13]. Patients having both CD 
and ulcerative colitis have more chances to have pancolitis as compared to patients 
having ulcerative colitis alone [14].
Oral lesions including erythema or atrophy, and soreness or burning sensation 
of the tongue have been associated with CD and can be resolved with gluten free 
diet.
Adult patients may rarely develop celiac crisis, presenting as profuse diarrhea 
and severe metabolic disturbances, if remained undiagnosed [15].
3. Nutrient deficiencies in CD
Now a days, many patients with CD, may presents with no or minor gastro-
intestinal symptoms. The anemia including microcytic due to iron deficiency, 
macrocytic either due to vitamin B12 or folic acid deficiencies or even normocytic 
due to combined deficiencies is the initial manifestation of CD [16]. The possible 
explanation for high prevalence of nutritional deficiencies among CD patients 
include insufficient nutritional intake.
One of the commonest complications of CD is iron deficiency anemia; these 
patients may remain undiagnosed till their adult life [17]. The major cause of iron 
deficiency anemia includes decreased dietary intake, reduced absorption and 
blood loss. Among these causes, blood loss remained the most important one and 
it can be due to various sites including abdomen or urogenital. Reduced absorption 
of iron is an uncommon cause of iron deficiency, especially in healthy individu-
als and in resource rich countries. Iron is absorbed in the upper GI tract, and the 
duodenum is the site of maximum absorption [18]. There are multiple medical 
conditions which may lead to reduced absorption, and among them celiac is not an 
uncommon cause. The other conditions are atrophic gastritis, helicobacter pylori 
infection and bariatric surgery. Normal heme iron and normal gastric environment 
without acid reducing medications, facilitates absorption [19]. CD can contribute 
to anemia by several mechanisms, including iron deficiency by reduced absorp-
tion of supplemental iron and malabsorption of the other nutrients required for 
RBC production including B12, folic acid and copper [20]. There may also be a 
component of anemia of chronic disease and blood loss. Although the exact cause 
of blood loss in CD is unclear [21]. The causative pathology among these patients 
either includes mucosal abnormalities leading to oesophagitis and gastritis, or 
occult gastrointestinal bleeding [22]. The occult bleeding is due to excessive loss 
of intestinal cells and/or malabsorption of peroxidase-containing foods rather 
than loss of red blood cells [23]. Although the occult bleeding is not a common 
manifestation among patients with CD, thus occult bleeding is not a major contrib-
uting factor to iron deficiency anemia [24]. The classical presentation among these 
patients is recurrent iron deficiency with no recovery on supplemental therapy. 
The presentation of iron deficiency among these patients may include mild iron 
deficiency to severe heart failure.
The water soluble vitamins are B6 and folic acid which absorbed proximally and 
B12 which absorbed distally are the other commonly deficient vitamins [25]. The fat 
soluble vitamin A and D are also deficient in CD. Among these water and fat soluble 
vitamins, folic acid is the deficient most varying from 18 to 90% [26], followed 
by B12, vitamin A and D respectively. Overall vitamin deficiencies are barely seen 
in healthy individuals except for vitamin B12 which is commonly seen in healthy 
individuals [27]. The clinical presentation of folic acid includes mild cheilitis and 
sore mouth. Vitamin B12 and B6 deficient patients although presents with more 
severe manifestation including neurological symptoms.
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There is deficiency of other minerals including magnesium, copper, and zinc. 
Minerals form only 5% of the typical human diet but are essential for normal 
health and function. Although magnesium deficiency in humans is very unusual, 
it has been seen in individuals on a highly restricted diet or with celiac disease [28]. 
Magnesium is absorbed throughout the small intestine but the co-efficient is very 
low, possibly as low as 5% [29]. Its absorption decreases following high dietary 
intake or when total body magnesium is sufficient [30]. Due to deficiency patients 
may develop scaly dermatitis and dyslipidemia. Copper is the other mineral which 
may reduce in CD. It is absorbed in the proximal small intestine and stomach [31]. 
Though rare, acquired copper deficiency has been seen in humans. The common 
causes include fore gut surgery, premature infants, chronic malabsorptive condi-
tions including CD and hemodialysis [32–34]. Copper deficiency may presents 
with fragile, abnormally-formed hairs, depigmentation of skin, muscle weakness 
and neurological abnormalities [35]. The neurological abnormalities are same as 
B12 deficiency. It may also causes anemia mimicking iron deficiency and neutro-
penia [36]. The other commonest deficient mineral is zinc. It is mainly absorbed in 
the duodenum and jejunum, and to a lesser extent in the ileum and large intestine 
[37]. In CD, the zinc deficiency may be due to increased endogenous losses of zinc, 
rather than abnormal zinc absorption. The clinical presentation of zinc deficiency 
includes wide array of skin lesions, growth retardation and hypogonadism [38]. 
The cell mediated immunity and antioxidants buffer capacity may be compro-
mised as well [39].
4. Neuropsychiatric complications of CD
There is an established association of CD with different neuropsychiatric 
symptoms including headache, peripheral neuropathy, ataxia, depression, dysthy-
mia, anxiety and epilepsy [40]. Peripheral neuropathies, characterized by burning, 
tingling, and numbness in hands and feet is quiet common among CD patients 
and sometimes the initial presentation as well. These neuropathies are associated 
with deficiencies of different vitamins including B1(thiamine), B2(riboflavin), 
B3(niacin), B6(pyridoxine), B12(cobalamin) and E, and mineral including cop-
per. However, these deficiencies occurred when there is severe and extensive 
bowel involvement. Neuropathies may also be associated with lymphoma as well. 
Patients presenting with neurological manifestation has significant structural and 
functional brain deficits on MRI as compared to controls. The exact mechanism in 
relation to depression and epilepsy is not clear yet [41]. Patients with peripheral 
neuropathies do not responded on gluten free diet as compared to other neurologi-
cal manifestations.
5. Metabolic bone disease and complications related to joints in CD
The relationship of bone derangement and CD has been recognized since a long 
time, and can occur with or without gastrointestinal symptoms (Table 2). Low 
mineral density, reduced bone mass and increased fragility leading to increased risk 
of fracture is commonly seen in CD. These bone alteration are the consequence of 
impaired calcium and vitamin D absorption and secondary hyperparathyroidism, 
resulting primarily from the loss of villous cells in the proximal intestine, where 
calcium is mostly absorbed accounting for 90% of overall calcium absorption 
[42]. Minor amount of calcium is absorbed from stomach and intestine, the colon 
accounts for <10% of calcium absorption. Calcium absorption from intestine, 
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reabsorption from the kidneys and excretion from bones is tightly controlled. 
Calcium balance is regulated through the calcitropic hormone, parathyroid hor-
mone, 1,25(OH)2 D3, exert complex coordinated activities to maintain normal 
serum calcium levels [43]. When the extracellular calcium concentration decreases, 
there is rapid increase in parathyroid hormone release that promotes bone turnover 
and calcium bone loss. Hyperparathyroidism (Figure 3) is common in patients 
with newly diagnosed CD, 27% in adults and 12–54% in children [44, 45]. It is 
more common in refractory C, rather than in those who responded on gluten free 
diet [46]. Low BMD in adult CD patients is related to secondary hyperparathyroid-
ism and osteomalacia due to calcium and vitamin D malabsorption [47]. Vitamin 
deficiency is present in both females and males accounting for 71 and 64% respec-
tively. Dietary vitamin D is absorbed as a fat soluble vitamin in small intestine, 
and because of intestinal involvement in CD its absorption decreases thus leading 
to deficiency of particular vitamin [48]. The other factor of hypovitaminosis 
is intestinal mucosal lesion [49]. Steatorrhea may also impair the absorption of 
25(OH)D undergoing enterohepatic circulation, especially in acute exacerbation of 
CD. In patients with CD, the regulation of 1,25(OH)2D3 is through genomic action 
involving the classical vitamin D receptor (VDR), although non genomic regula-
tor is also involved in its absorption [50]. VDR is normally expressed in duodenal 
mucosa of patients with CD, notwithstanding mucosal damage and atrophy of villi 
[51]. Although there is no difference in frequency of VDR gene is seen in patients 
with CD and healthy subjects, therefore VDR gene is unrelated to low BMD [52]. 
The main factor is reduced calbindin and calcium binding protein due to damaged 
intestinal mucosa which leads to calcium loss and secondary hyperparathyroidism 
[53]. In atypical patients of CD, many presented with back pain, diffuse musculo-
skeletal pain and proximal muscle weakness, due to osteomalacia, osteopenia and 
osteoporosis. All these patients have low BMD.
Factors Mechanism of action
Hypocalcaemia Vitamin D deficiency
Intestinal mucosal damage
Alterations in calcium-transport mechanism
Inadequate calcium intake
Reduced consumption of dairy products
Steatorrhea
Hypovitaminosis D Alterations in vitamin D metabolism
Decreased level of vitamin D-binding proteins
Decreased intake of vitamin D
Steatorrhea
Bowel inflammation hormones Chronic release of proinflammatory cytokines
PTH
Estrogens and androgens
Corticosteroids Reduction of intestinal calcium absorption
Increase of renal calcium excretion
Impairment of osteoblast function
Alteration of osteoclast resorption cycle
Additional risk factors Autoimmune alternations
Diagnosis in adult life
Lapses from GFD
Active disease
Low BMI
Lifestyle factors
Table 2. 
Factors contributing to bone alteration in celiac disease.
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Osteopenia is found in in almost all patients with CD, either treated or 
untreated. It is even more common in patients who remained unrecognized. 
The prevalence of osteopenia and osteoporosis in adult is around 14–35% [54]. 
Osteoporosis (Figures 4, 5) is characterized by low bone mass, micro architectural 
disruption and skeletal fragility resulting in decreased bone strength and increase 
risk fracture. It is not only dependent on BMD, but also related to rate of bone 
formation and resorption, bone size and shape and micro architecture. It has no 
clinical manifestation until one developed pain due to fracture. The commonest site 
of involvement of osteoporosis is either lumbar spine or neck of femur or radius. 
The commonest site of involvement is also lumbar spine accounting almost 26% 
[48]. The risk is almost doubled as compared to general population. It is more 
common in peripheral skeleton and common in males with classical presentation 
than females. Loss of bone density is much increased in older patients with late 
diagnosis as compared to younger patients and usually not resolved completely with 
gluten free diet. There is increased fracture risk, almost doubled in CD patients as 
compared to general population [55].
Children with CD are at risk of reduced BMD, hyperparathyroidism, decreased 
calcium especially in those with untreated CD [56]. They may or may not have 
Figure 3. 
Hyperparathyroidism.
Figure 4. 
Cross-section of bone tissue-osteoporosis.
Celiac Disease - From the Bench to the Clinic
8
associated gastrointestinal symptoms. There is also risk less-than optimal peak bone 
mass leading to growth retardation as well. Bone density increases until the end of 
puberty. If there is lack of achievement of proper peak mass, there is more chance of 
development of osteoporosis in adulthood [57]. The rate of bone metabolism is also 
altered in children with CD, which is another factor for osteopathy [58]. In children 
who are unable to catch up growth need to be evaluated for concomitant growth 
hormone deficiency, as growth hormone exert its effect on bone mineral density.
Patients with CD commonly have osteomalacia (Figures 6, 7) as well and 
presenting as aches and pain with bone tenderness unlike to osteoporosis. These 
patients also presented with proximal myopathy and spontaneous fracture [59]. 
The exact prevalence of osteomalacia though is not clear in CD [60]. The major 
factor for development of osteomalacia is decreased absorption of calcium and 
vitamin D. Diet plays a major and important role in proper bone mineralization. A 
gluten free diet is low in nutrient, vitamins and minerals, including calcium [61]. 
Figure 5. 
Radiology-osteoporosis.
Figure 6. 
Tri-radiate pelvis-osteomalacia.
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Thus they consume less vitamin D and calcium, as compared to normal diet [62]. 
It further decreases due to lactose intolerance resulting from decreased lactate 
production by the damaged villi. This factor further decreases BMD, and aggravates 
osteoporosis and osteopenia.
Osteoarthritis is the most common type of arthritis world over. It is inflam-
matory condition due to damage of cartilage involving any joint of the body. It is 
commonly presents in patients with CD, but the exact causal relationship is not 
known [63].
6. Malignancies associated with CD
The most important complication of CD is development of cancer. The inci-
dence of gastrointestinal and non-gastrointestinal both is common among CD 
patients. The commonest among the malignancies is the gastrointestinal lympho-
mas accounting for 18% of all cancers. The gastrointestinal tract is the predominant 
site of extranodal lymphoma involvement. Primary lymphomas are less common 
than secondary lymphomas. Primary lymphomas typically involve any section 
of gastrointestinal tract from oropharynx to rectum [64]. It can involve single or 
multiple sites. These are usually non-Hodgkin’s lymphomas although Hodgkin’s 
lymphoma has been reported as well. The commonest site of involvement of 
non-Hodgkin’s lymphoma is stomach, present in 68–75%, followed by small bowel 
than ileocecal junction. Diffuse colonic involvement is present only in 1% [65]. 
Distribution of primary lymphomas varies among population; gastric lymphoma 
is more common in United States, while intestinal lymphoma is seen in Middle 
East and Mediterranean areas. GI Lymphomas are commonly seen in patients with 
helicobacter pylori infection, autoimmune disease, immunodeficiency and immu-
nosuppressive states, inflammatory bowel disease and CD. Both the T and B cell are 
commonly seen in patients with CD. The exact etiology of development of these 
malignancies is under controversy, both the autoimmune and inflammatory factors 
contribute to the risk. The T cell variant enteropathy-associated T-cell lymphoma 
(EATL) (Figure 8) involving the small intestine mostly, is the commonest malig-
nancy seen in celiac disease, although uncommonly seen [66, 67]. It is most com-
monly found in adult males with a median age of 60 years. EATL patients mostly 
presented with acute bleeding, perforation or obstruction, or it should always be 
suspected if there is clinical deterioration of CD, despite on a strict gluten free diet. 
It is highly suggested to screen a patient for CD, even if not diagnosed before, if 
Figure 7. 
Looser’s zone-osteomalacia.
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presented with EATL. Patients with enteropathy associated T cell lymphoma of the 
small intestine, involving jejunum demonstrates large circumferential ulcer without 
overt mass. The involved area typically shows lymphoma, while the non-involved 
sites usually show villous atrophy.
The other variant of EATL, ulcerative enteritis, is another complication of long 
standing and refractory sprue. It presents with abdominal pain, nausea, vomiting and 
diarrhea. The other complication of CD includes intestinal ulceration independent 
of lymphoma and so called refractory sprue and collagenous sprue (Figure 9). It is a 
clinicopathological entity characterized by diarrhea and malabsorption accompanied 
by the histological findings of subepithelial collagen deposition and severe villous 
atrophy of small bowel mucosa [68]. The occurrence of collagenous sprue has been 
seen in patients with celiac disease, tropical sprue, milk intolerance and common 
variable immunodeficiency states [69]. Regardless of etiology it has a poor prognosis. 
Collagenous sprue associated with CD usually does not respond to gluten free diet and 
has a poor prognosis [70].
Figure 8. 
Lymphoma.
Figure 9. 
Collagenous colitis.
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The risk of other digestive tract malignancies is also commonly seen in CD 
patients, including oropharyngeal, colorectal, small intestinal adenocarcinoma and 
hepatocellular carcinomas. In oropharyngeal carcinomas, the commonest is the 
squamous cell carcinoma. In contrast to gastrointestinal carcinomas, the non-
gastrointestinal malignancies, including breast carcinomas are not seen commonly 
in CD patients. There is no evidence that gluten free diet may decrease the develop-
ment of malignancies in CD.
7. Hyposplenism in CD
One of the earliest manifestations of CD is hyposplenism, though the exact 
mechanism of development of hyposplenism is not known. Due to hyposplen-
ism there is increased susceptibility of infection due to encapsulated bacteria 
especially. Vaccination against prophylaxis for pneumococcus is not highly recom-
mended [71, 72].
8. Venous thromboembolism in CD
Hypercoagulability with elevated homocysteine level and low vitamin-K-depen-
dent anti-coagulant proteins (protein C & S) are relatively common in CD patients. 
Due to these factors, i.e. increased homocysteine level and decreased protein C &S, 
along with autoimmunity of CD, there might be increased susceptibility to venous 
thromboembolism. Although not commonly observed in CD patients [73].
9. Kidney disease in CD
Glomerular IgA deposition is common, occurring in as many as one-third of 
patients. Although the clinical manifestation is not evident, due to no associated 
complement deficiency. This indicates that a high circulating load of polyclonal 
IgA is not adequate to cause nephritis, but other abnormalities of IgA are necessary 
to translate into mesangial activation and glomerular injury. This mesangial IgA 
deposition is also seen in healthy individuals from 3 to 16% [74]. Thus its associa-
tion with other disease is relatively high.
10. Idiopathic pulmonary hemosiderosis in CD
Lane-Hamilton syndrome, the co-existence of CD and idiopathic pulmonary 
hemosiderosis, is not an uncommon entity in CD patients, although the exact 
prevalence is not known [75]. It is a rare lung disease characterized by alveolar 
capillary bleeding and accumulation of hemosiderin in the lungs. Diffuse alveolar 
hemorrhage is characterized by hemoptysis, dyspnea, alveolar opacities on chest 
X-ray and anemia. It may lead to iron loss through swallowing of iron-laden alveolar 
or bronchial epithelial cells. This may lead to functional iron deficiency [76].
11. Dental defects in CD
Oral manifestations are overlooked in CD patients; the long list of clinical signs 
and symptoms associated with CD includes dental enamel hypoplasia, aphthous 
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ulcers and delayed eruption of teeth [77]. The dental enamel defects are more 
common in deciduous dentition. It can involve all four quadrants, but more com-
monly involved maxillary and mandibular incisors and molars [78]. The exact cause 
is not understood but it may be due to increased level of HLA DR3 in their blood. 
This antigen has an association with celiac disease. Dental enamel hypoplasia, a 
nutritionally related defect of the enamel, presented as pits, lines or grooves on 
the teeth. Its prevalence ranges from 10 to 97%, and appears to more common in 
children with CD, as compared to adults [79]. Its prevalence in CD, is much higher 
than general population, and it is contributed both to nutritional and immunologi-
cal factors. Another enamel defect, either partial or complete, can sometimes be 
the only symptoms in children with CD. It is thus advisable to screen children with 
enamel defects for CD. The other oral manifestation aphthous ulcer or canker sores 
are also seen in CD, though not specific for CD. Aphthous ulcers, though regresses 
on gluten free diet [80].
Delayed tooth eruption, another manifestation of CD, has been reported in 27% 
of patients with CD. The possible cause is probably malnutrition. A high prevalence 
of enamel hypoplasia is around 66% in CD patients. Formation of plaque is less 
frequent in patients who are on gluten free diet, probably because of multiple meals 
in between and use of fluoride toothpaste.
There are other oral problem related to celiac disease, which include recurrent 
aphthous stomatitis, atrophic glossitis, dry mouth syndrome and squamous cell 
carcinoma of the oropharynx.
12. Reproductive complications in CD
Females with untreated CD may have multiple complications in relation to 
reproductive problems. They may have late menarche, recurrent miscarriages, 
infertility, preterm delivery and low birth weight. These patients may directly 
presented with these problems and do not have any gastrointestinal issues. All these 
issues can be resolved with gluten free diet [81].
Males with CD also have infertility, characterized by sperm dysmotility and 
morphological changes. They may also have androgen resistance leading to infertil-
ity. All these can be resolved with gluten free diet [82].
13. Cardiac complications in CD
Autoimmune myocarditis and idiopathic dilated cardiomyopathy are associated 
with CD, though the prevalence is 5%. Not all patients have gastrointestinal symp-
toms but almost all of them iron deficiency anemia. These patients responded on 
gluten free diet with or without immunosuppressive therapy [83].
These patients also have strong association with ischemic heart disease as well.
14. Autoimmune diseases in CD
CD is closely associated with other autoimmune illnesses, like type 1 diabetes 
mellitus and autoimmune thyroiditis. Type 1 diabetes mellitus and CD has strong 
genetic association with HLA-DR3, HLA-DQ2, and HLA-DQ8 [84]. Because of the 
same genetic association, they share same pathogenesis of tissue damage from auto-
immunity or intolerance to dietary antigen. The patients with HLA-DQ2 also have 
raised IgA autoantibodies to tissue transglutaminase and thus likely to have CD with 
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type 1 diabetes mellitus. Although age of onset of diabetes mellitus is not dependent 
of CD, neither it triggers the autoimmunity leading to it. Whether a gluten free diet 
helps in improvement of diabetes mellitus is not clear yet.
There is increased incidence of autoimmune thyroiditis among patients with 
CD, and hypothyroidism is more common. Association of CD, autoimmune thy-
roiditis and type 1 diabetes mellitus is part of polyglandular autoimmune syndrome 
type 111.
15. Liver disease in CD
CD may be associated with nonspecific mild chronic elevation in serum ami-
notransferase levels. AST ranges from 29 to 80 while ALT from 60 to 130. These 
increased transaminases may get normalize with gluten free diet. Patients with CD 
may also have severe liver disease including congenital liver fibrosis, massive steato-
sis, and progressive hepatitis of unknown origin [85]. There is also an association of 
primary biliary cirrhosis and primary sclerosing cholangitis with CD.
16. Skin manifestation in CD
Dermatitis herpetiformis in CD is the commonest and pathognomonic skin 
lesion. It presents usually on external surface in grouped in the form intensely 
pruritic papules and vesicles. The diagnosis is confirmed on histology by the dem-
onstration of granular IgA deposits along the non-affected subepidermal basement 
membrane [86]. Similar to CD they have increased antibodies against tissue trans-
glutaminase IgG. Dermatitis herpetiformis and CD, are associated with HLA-DQ 
alpha beta heterodimers, and may have association with other autoimmune illness 
as well. It responds well on gluten free diet though requires longer duration.
Patients with CD, also have increased incidence of atopic dermatitis as compared 
to general population [87].
17. Mortality in CD
There is an increased mortality in patients with CD, due to severe clinical course 
but as a whole the data is inconclusive. There is twofold rise in death especially in 
severe disease [88]. The increased mortality is mostly associated with malignant 
and cardiovascular diseases [89].
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